Search Results - María Eugenia Olmedo

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Targeting KRAS in Non-Small Cell Lung Cancer

    Targeting KRAS in Non-Small Cell Lung Cancer by Elena Corral de la Fuente, Maria Eugenia Olmedo Garcia, Ana Gomez Rueda, Yolanda Lage, Pilar Garrido

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Treating -mutant NSCLC: latest evidence and clinical consequences

    Treating -mutant NSCLC: latest evidence and clinical consequences by Pilar Garrido, María Eugenia Olmedo, Ana Gómez, Luis Paz Ares, Fernando López-Ríos, Juan Manuel Rosa-Rosa, José Palacios

    Published 2017-09-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    464 2SMALL (NCT04253145) phase I part: lurbinectidine (LUR) in combination with atezolizumab (ATZ) for second line extensive stage small cell lung cancer (ES-SCLC) patients (pts)

    464 2SMALL (NCT04253145) phase I part: lurbinectidine (LUR) in combination with atezolizumab (ATZ) for second line extensive stage small cell lung cancer (ES-SCLC) patients (pts) by Luis Paz-Ares, Santiago Ponce Aix, Alejandro Navarro, Reyes Bernabe, Maria Eugenia Olmedo, Trigo Jose Manuel, Jon Zugazagoitia Fraile

    Published 2021-11-01
    Article
    Save to List
    Saved in:
  4. 4
    Response to Mobocertinib in a patient with advanced Non-Small Cell Lung Cancer harboring EGFR exon 20 insertion after several therapies including Amivantamab

    Response to Mobocertinib in a patient with advanced Non-Small Cell Lung Cancer harboring EGFR exon 20 insertion after several therapies including Amivantamab by Elena Corral de la Fuente, María Eugenia Olmedo García, Inmaculada Orejana Martín, Amparo Benito Berlinches, Ana Gómez Rueda, Yolanda Lage Alfranca, Pilar Garrido

    Published 2022-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    ALK rearranged non–small cell lung carcinoma with EML4-NTRK3 fusion as a possible mechanism of resistance to third-generation ALK inhibitors

    ALK rearranged non–small cell lung carcinoma with EML4-NTRK3 fusion as a possible mechanism of resistance to third-generation ALK inhibitors by Elena Corral de la Fuente, Amparo Benito Berlinches, Ana Gomez Rueda, María Eugenia Olmedo García, Yolanda Lage Alfranca, Margaret Lario, Almudena Santón Roldán, Pilar Garrido

    Published 2021-12-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Efficacy of immunotherapy in sarcomatoid lung cancer, a case report and literature review

    Efficacy of immunotherapy in sarcomatoid lung cancer, a case report and literature review by Magda Palka Kotlowska, Ana Gómez Rueda, María Eugenia Olmedo, Amparo Benito, Almudena Santón Roldán, Maria Angeles Fernandez Méndez, Luis Gorospe, José Palacios, Pilar Garrido López

    Published 2019-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer

    Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer by Juan Moreno-Rubio, Santiago Ponce, Rosa Álvarez, María Eugenia Olmedo, Sandra Falagan, Xabier Mielgo, Fátima Navarro, Patricia Cruz, Luis Cabezón-Gutiérrez, Carlos Aguado, Gonzalo Colmenarejo, Marta Muñoz-Fernández de Leglaria, Ana Belén Enguita, María Cebollero, Amparo Benito, Isabel Alemany, Carolina del Castillo, Ricardo Ramos, Ana Ramírez de Molina, Enrique Casado, Maria Sereno

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: